Wegovy Approved to Cut Heart Disease and Stroke Risk - Futurism
- Wegovy Approved to Cut Heart Disease and Stroke Risk Futurism
- Novo Nordisk's Wegovy wins FDA approval for cutting heart disease risks, in move that could expand insurance coverage CNBC
- Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug Fox Business
- FDA Approves Semaglutide for Cardiovascular Risk Reduction Medscape
- Weight-loss drug Wegovy can be marketed for heart benefits after FDA label update CNN